SarCNU in Treating Patients With Recurrent Malignant Glioma

NCT00036660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: SarCNU

Sponsor

NCIC Clinical Trials Group